Product Information
TEMAZEPAM 7.5 MG CAPSULE is a generic product labeled by Solco Healthcare US LLC, priced at $0.8337 per EA under NDC 43547061110. Its NADAC has been published 164 times since Aug 16, 2023.
FDA first approved this application on Jun 4, 2015. Its Orange Book therapeutic-equivalence code is AB — FDA rates it therapeutically equivalent to (substitutable for) its reference product.
Strength
7.5 mg/1
Manufacturer
Solco Healthcare US LLCNDC
43547061110
Classification
Generic
Dosage Form
CAPSULE
Route
ORAL
Effective Date
9/23/2026
Active Ingredients
TEMAZEPAMApproval Type
Generic (ANDA)
FDA Application
ANDA201781FDA Approved
6/4/2015
TE Code
AB
On Market Since
1/5/2023
Pharmacological Classes
Price Statistics
The NADAC for TEMAZEPAM 7.5 MG CAPSULE has been published 164 times since Aug 16, 2023, and over the history we have for it it has risen 2.5%. The table below summarizes its recorded NADAC range and movement.
| Current price | $0.8337 per EA |
|---|---|
| All-time high | $1.5515 (Apr 10, 2024) |
| All-time low | $0.7393 (Nov 20, 2024) |
| 52-week high | $0.9537 |
| 52-week low | $0.7894 |
| Median price | $0.9273 |
| Average price | $1.0135 |
| Largest weekly change | +51.7% (Aug 21, 2024) |
| Weeks tracked | 164 |
| Tracking since | Aug 16, 2023 |
Generic Alternatives
The matcher finds 2 manufacturers offering a NADAC-published product with this drug's active ingredient and strength in a comparable dosage form (cheapest from each manufacturer, up to 10 shown below). None of the shown alternatives sit below the current price. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.
Related Drugs
Same classification
Continue researching this drug
Use these direct paths to move from a single NDC into the surrounding market, manufacturer, class, and trend context.
Manufacturer
Solco Healthcare US LLC manufacturer profile
See the full portfolio, pricing trend, and other products from this labeler.
Drug market
temazepam market comparison
Compare this molecule across participating manufacturers and inspect the broader market price spread.
Therapeutic class
Benzodiazepine class view
See how this drug behaves alongside other products in the same FDA pharmacologic class.
Trend hub
Latest market trends
Zoom back out to the weekly mover view and compare this NDC with the rest of the current NADAC release.
Guide
Understanding NADAC pricing
Use the explainer when you need context on how CMS publishes NADAC and how to interpret the number on this page.
Frequently asked questions
What is the NADAC price of TEMAZEPAM 7.5 MG CAPSULE?
The current National Average Drug Acquisition Cost (NADAC) for TEMAZEPAM 7.5 MG CAPSULE, manufactured by Solco Healthcare US LLC, is $0.8337 per EA (NDC 43547061110), effective Sep 30, 2026.
How has the price of TEMAZEPAM 7.5 MG CAPSULE changed over time?
Over the history we have for it, the NADAC for TEMAZEPAM 7.5 MG CAPSULE has risen 2.5%. It has been tracked across 164 weekly CMS publications since Aug 16, 2023.
What are the highest and lowest recorded NADAC prices for TEMAZEPAM 7.5 MG CAPSULE?
Since Aug 16, 2023, the NADAC for TEMAZEPAM 7.5 MG CAPSULE has ranged from a low of $0.7393 (Nov 20, 2024) to a high of $1.5515 (Apr 10, 2024), with a median of $0.9273 per EA.
Are there cheaper alternatives to TEMAZEPAM 7.5 MG CAPSULE?
2 manufacturers publish a NADAC-priced product with the same active ingredient and strength as TEMAZEPAM 7.5 MG CAPSULE in a comparable dosage form, but none are currently priced below it.
Who manufactures TEMAZEPAM 7.5 MG CAPSULE?
TEMAZEPAM 7.5 MG CAPSULE (NDC 43547061110) is labeled by Solco Healthcare US LLC, and CMS classifies it as a generic product.